Search hospitals > Texas > Amarillo
The Don and Sybil Harrington Cancer Center
Claim this profileAmarillo, Texas 79106
Global Leader in Cancer
Global Leader in Lung Cancer
Conducts research for Breast Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Recurrence
91 reported clinical trials
4 medical researchers
Summary
The Don and Sybil Harrington Cancer Center is a medical facility located in Amarillo, Texas. This center is recognized for care of Cancer, Lung Cancer, Breast Cancer, Non-Small Cell Lung Cancer, Recurrence and other specialties. The Don and Sybil Harrington Cancer Center is involved with conducting 91 clinical trials across 198 conditions. There are 4 research doctors associated with this hospital, such as Anita Ravipati, Daniel Arsenault, Brian T. Pruitt, and Jeffery D. Hanrahan.Area of expertise
1Cancer
Global LeaderStage I
Stage IV
Stage II
2Lung Cancer
Global LeaderStage III
Stage IV
Stage II
Top PIs
Anita RavipatiThe Don and Sybil Harrington Cancer Center1 year of reported clinical research
Expert in Cancer
Expert in Lung Cancer
26 reported clinical trials
50 drugs studied
Daniel ArsenaultThe Don and Sybil Harrington Cancer Center10 years of reported clinical research
Studies Breast Cancer
2 reported clinical trials
6 drugs studied
Brian T. PruittThe Don and Sybil Harrington Cancer Center5 years of reported clinical research
Studies Breast Cancer
Studies Cancer
2 reported clinical trials
4 drugs studied
Jeffery D. HanrahanThe Don and Sybil Harrington Cancer Center7 years of reported clinical research
Studies Ovarian Choriocarcinoma
Studies Testicular Carcinoma
1 reported clinical trial
5 drugs studied
Clinical Trials running at The Don and Sybil Harrington Cancer Center
Breast Cancer
Lung Cancer
Non-Small Cell Lung Cancer
Rectal Cancer
Cancer
Ovarian Tumors
Colorectal Cancer
Ovarian Choriocarcinoma
Testicular Carcinoma
Ovarian Carcinoma
Chemotherapy + Hormone Therapy
for Breast Cancer
This Phase III Trial will determine whether adjuvant chemotherapy (ACT) added to ovarian function suppression (OFS) plus endocrine therapy (ET) is superior to OFS plus ET in improving invasive breast cancer-free survival (IBCFS) among premenopausal, early- stage breast cancer (EBC) patients with estrogen receptor (ER)-positive, HER2-negative tumors and 21-gene recurrence score (RS) between 16-25 (for pN0 patients) and 0-25 (for pN1 patients).
Recruiting2 awards Phase 319 criteria
Symptom Monitoring
for Young Women on Hormone Therapy
This phase III trial compares the effect of active symptom monitoring and patient education to patient education alone in helping young women with stage I-III breast cancer stay on their hormone therapy medicines. The patient education tool contains interactive weblinks which provide patients with education material about breast cancer and side effects of therapy. Symptom monitoring is a weblink via email or text message with questions asking about symptoms. Hormone therapy for breast cancer can cause side effects, and may cause some women to stop treatment early. Asking about symptoms more often may help women keep taking hormone therapy medicines.
Recruiting1 award N/A13 criteria
T-DM1 + Tucatinib
for Breast Cancer
This study is evaluating whether a combination of two drugs may help prevent breast cancer from coming back.
Recruiting1 award Phase 313 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at The Don and Sybil Harrington Cancer Center?
The Don and Sybil Harrington Cancer Center is a medical facility located in Amarillo, Texas. This center is recognized for care of Cancer, Lung Cancer, Breast Cancer, Non-Small Cell Lung Cancer, Recurrence and other specialties. The Don and Sybil Harrington Cancer Center is involved with conducting 91 clinical trials across 198 conditions. There are 4 research doctors associated with this hospital, such as Anita Ravipati, Daniel Arsenault, Brian T. Pruitt, and Jeffery D. Hanrahan.